1. Home
  2. YMAB vs SD Comparison

YMAB vs SD Comparison

Compare YMAB & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • SD
  • Stock Information
  • Founded
  • YMAB 2015
  • SD 2006
  • Country
  • YMAB United States
  • SD United States
  • Employees
  • YMAB N/A
  • SD N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • SD Oil & Gas Production
  • Sector
  • YMAB Health Care
  • SD Energy
  • Exchange
  • YMAB Nasdaq
  • SD Nasdaq
  • Market Cap
  • YMAB 386.7M
  • SD 429.3M
  • IPO Year
  • YMAB 2018
  • SD 2007
  • Fundamental
  • Price
  • YMAB $8.61
  • SD $11.73
  • Analyst Decision
  • YMAB Buy
  • SD
  • Analyst Count
  • YMAB 10
  • SD 0
  • Target Price
  • YMAB $13.91
  • SD N/A
  • AVG Volume (30 Days)
  • YMAB 874.6K
  • SD 249.4K
  • Earning Date
  • YMAB 11-07-2025
  • SD 11-05-2025
  • Dividend Yield
  • YMAB N/A
  • SD 4.08%
  • EPS Growth
  • YMAB N/A
  • SD 86.17
  • EPS
  • YMAB N/A
  • SD 2.03
  • Revenue
  • YMAB $85,385,000.00
  • SD $146,165,000.00
  • Revenue This Year
  • YMAB N/A
  • SD $30.71
  • Revenue Next Year
  • YMAB $13.97
  • SD $10.06
  • P/E Ratio
  • YMAB N/A
  • SD $5.79
  • Revenue Growth
  • YMAB N/A
  • SD 13.89
  • 52 Week Low
  • YMAB $3.55
  • SD $8.81
  • 52 Week High
  • YMAB $16.11
  • SD $13.19
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.21
  • SD 57.03
  • Support Level
  • YMAB $8.50
  • SD $11.33
  • Resistance Level
  • YMAB $8.56
  • SD $11.65
  • Average True Range (ATR)
  • YMAB 0.02
  • SD 0.28
  • MACD
  • YMAB -0.12
  • SD -0.03
  • Stochastic Oscillator
  • YMAB 100.00
  • SD 48.48

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About SD SandRidge Energy Inc.

SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.

Share on Social Networks: